Definium Therapeutics, Inc. (DFTX)

Definium Therapeutics Statistics

Total Valuation

DFTX has a market cap or net worth of $1.63 billion. The enterprise value is $1.54 billion.

Market Cap	1.63B
Enterprise Value	1.54B

Important Dates

The next estimated earnings date is Thursday, March 5, 2026, before market open.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

DFTX has 98.51 million shares outstanding. The number of shares has increased by 42.97% in one year.

Current Share Class	98.51M
Shares Outstanding	98.51M
Shares Change (YoY)	+42.97%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	0.96%
Owned by Institutions (%)	41.87%
Float	97.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	10.52
P/TBV Ratio	15.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.31.

Current Ratio	3.30
Quick Ratio	3.20
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-31.05

Financial Efficiency

Return on equity (ROE) is -85.59% and return on invested capital (ROIC) is -41.26%.

Return on Equity (ROE)	-85.59%
Return on Assets (ROA)	-33.95%
Return on Invested Capital (ROIC)	-41.26%
Return on Capital Employed (ROCE)	-88.16%
Weighted Average Cost of Capital (WACC)	18.44%
Revenue Per Employee	n/a
Profits Per Employee	-$2.27M
Employee Count	74
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +130.67% in the last 52 weeks. The beta is 2.62, so DFTX's price volatility has been higher than the market average.

Beta (5Y)	2.62
52-Week Price Change	+130.67%
50-Day Moving Average	14.05
200-Day Moving Average	10.45
Relative Strength Index (RSI)	58.13
Average Volume (20 Days)	2,133,769

Short Selling Information

The latest short interest is 16.83 million, so 17.09% of the outstanding shares have been sold short.

Short Interest	16.83M
Short Previous Month	n/a
Short % of Shares Out	17.09%
Short % of Float	17.25%
Short Ratio (days to cover)	7.51

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-151.19M
Pretax Income	-168.10M
Net Income	-168.10M
EBITDA	-151.67M
EBIT	-151.19M
Earnings Per Share (EPS)	-$1.98

Balance Sheet

The company has $209.07 million in cash and $40.99 million in debt, with a net cash position of $168.09 million or $1.71 per share.

Cash & Cash Equivalents	209.07M
Total Debt	40.99M
Net Cash	168.09M
Net Cash Per Share	$1.71
Equity (Book Value)	130.60M
Book Value Per Share	1.70
Working Capital	150.43M

Cash Flow

Operating Cash Flow	-113.94M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DFTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.97%
Shareholder Yield	-42.97%
Earnings Yield	-9.85%
FCF Yield	n/a

Analyst Forecast

The average price target for DFTX is $33.00, which is 99.40% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.00
Price Target Difference	99.40%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 29, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date	Aug 29, 2022
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1